Cargando…
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach
BACKGROUND: Gene expression profiling is increasingly being utilised as a diagnostic, prognostic and predictive tool for managing cancer patients. Single-sample scoring approach has been developed to alleviate instability of signature scores due to variations from sample composition. However, it is...
Autores principales: | Mao, Yizhe, Gide, Tuba N., Adegoke, Nurudeen A., Quek, Camelia, Maher, Nigel, Potter, Alison, Patrick, Ellis, Saw, Robyn P. M., Thompson, John F., Spillane, Andrew J., Shannon, Kerwin F., Carlino, Matteo S., Lo, Serigne N., Menzies, Alexander M., da Silva, Inês Pires, Long, Georgina V., Scolyer, Richard A., Wilmott, James S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103529/ https://www.ncbi.nlm.nih.gov/pubmed/37055772 http://dx.doi.org/10.1186/s12967-023-04092-9 |
Ejemplares similares
-
Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies
por: Adegoke, Nurudeen A, et al.
Publicado: (2023) -
Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies
por: Gide, Tuba N., et al.
Publicado: (2023) -
Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients
por: Gide, Tuba N., et al.
Publicado: (2019) -
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets
por: Gide, Tuba N., et al.
Publicado: (2021) -
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
por: Conway, Jordan W, et al.
Publicado: (2022)